Serotonin-mediated increases in the extracellular levels of β-endorphin in the arcuate nucleus and nucleus accumbens: A microdialysis study

Journal of Neurochemistry

Volumn 73, Issue 6, 1999, Pages 2569-2574

  Zangen, Abraham ^a   Nakash, Rachel ^a   Yadid, Gal ^a  

^a BAR ILAN UNIVERSITY   (Israel)

Author keywords

Endorphin; Arcuate nucleus; Fluoxetine; Microdialysis; Nucleus accumbens; Serotonin

Indexed keywords

5,7 DIHYDROXYTRYPTAMINE; BETA ENDORPHIN; FLUOXETINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; CONCENTRATION RESPONSE; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SECRETION; RAT; SEROTONINERGIC SYSTEM; TISSUE DISTRIBUTION;

5,7-DIHYDROXYTRYPTAMINE; AFFECT; ANIMALS; ANTIDEPRESSIVE AGENTS; ARCUATE NUCLEUS; BETA-ENDORPHIN; EMOTIONS; EXTRACELLULAR SPACE; FLUOXETINE; MALE; MICRODIALYSIS; NUCLEUS ACCUMBENS; PAIN; RATS; RATS, SPRAGUE-DAWLEY; REWARD; SEROTONIN; SEROTONIN AGENTS; SEROTONIN UPTAKE INHIBITORS;

ANIMALIA;

EID: 0032725401     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0732569.x     Document Type: Article

References (36)

1. Amalric M., Cline E. J., Martinez J. L. Jr., Bloom F. E., and Koob G. F. (1987) Rewarding properties of β-endorphin as measured by conditioned place preference. Psychopharmacology (Berl.) 91, 14-19.
2. Baumgarten H. G., Bjorklund L., Lachenmayer L., and Nobin A. (1971) Evaluation of the effect of 5,7-dihydroxytryptamine on serotonin and dopamine neurons in the rat CNS. Acta Physiol. Scand. Suppl 391, 1-19.
3. Benveniste H. and Huttenmeier P. C. (1990) Microdialysis: theory and application. Prog. Neurobiol. 35, 195-215.
4. Blier P. and DeMontigny C. (1994) Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15, 220-226.
5. Bloom F. E., Siegal D., Ling N., and Guillemin R. (1976) Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness. Science 194, 630-632.
6. Bloom F. E., Battenberg E., Rossier J., Ling N., and Guillemin R. (1978a) Neurons containing β-endorphin in rat brain exist separately from those containing enkephalin: immunocytochemical studies. Proc. Natl. Acad. Sci. USA 75, 1591-1595.
7. Bloom F. E., Rossier J., Battenberg E. L. F., Bayon A., French E., Hendriksen S. J., Siggins G. R., Segal D., Browne R., Ling N., and Guillemin R. (1978b) Beta endorphin: cellular localization, electrophysiological and behavioral effects. Adv. Biochem. Psychopharmacol. 18, 89-109.
8. Brown R. S. and Bottomley W. K. (1990) The utilization and mechanism of action of tricyclic antidepressants in the treatment of chronic facial pain: a review of the literature. Anesth. Prog. 37, 223-229.
9. Breier A. (1989) Experimental approaches to human stress research: assessment of neurobiological mechanisms of stress in volunteers and psychiatric patients. Biol. Psychiatry 26, 438-462.
10. Cabib S. and Puglisi-Allegra S. (1996) Stress, depression and the mesolimbic dopamine system. Psychopharmacology (Berl.) 128, 331-342.
11. Darko D. F., Irwin M. R., Risch S. C., and Gillin J. C. (1992a) Plasma β-endorphin and natural killer cell activity in major depression: a preliminary study. Psychiatry Res. 43, 111-119.
12. Darko D. F., Risch S. C., Gillin J. C., and Golshan S. (1992b) Association of beta-endorphin with specific clinical symptoms of depression. Am. J. Psychiatry 149, 1162-1167.
13. De Deurwaerdère P., Bonhomme N., Lucas G., Le Moal M., and Spampinato U. (1996) Serotonin enhances striatal dopamine outflow in vivo through dopamine uptake sites. J. Neurochem. 66, 210-215.
14. Foley K. M., Kourides I. A., Inturrisi C. E., Kaiko R. F., Zaroulis C. G., Posner J. B., Houde R. W., and Li C. H. (1979) β-Endorphin: analgesic and hormonal effects in human. Proc. Natl. Acad. Sci. USA 76, 5377-5381.
15. France R. D. and Urban B. J. (1991) Cerebrospinal fluid concentrations of beta-endorphin in chronic low back pain patients. Influence of depression and treatment. Psychosomatics 32, 72-77.
16. Goodwin G. M., Austin M. P., Curran S. M., Rose M., Murray C., Prentice N., Ebmeier K. P., Bennie J., Carroll S., and Dick H. (1993) The elevation of plasma β-endorphin levels in major depression. J. Affect. Disord. 29, 281-289.
17. 3H]dopamine via reversal of the dopamine transporter in rat striatum and nucleus accumbens: a comparison with release elicited by potassium, N-methyl-D-aspartic acid, glutamic acid and D-amphetamine. J. Pharmacol. Exp. Ther. 262, 356-364.
18. Koob G. F. (1992) Drug of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13, 177-184.
19. Loh H. H., Tseng L. F., Wei E., and Li C. H. (1976) β-Endorphin is a potent analgesic agent. Proc. Natl. Acad. Sci. USA 73, 2895-2898.
20. Magni G. (1991) The use of antidepressants in the treatment of chronic pain. A review of current evidence. Drugs 42, 730-748.
21. Naber D., Picker D., Post R. M., Van Kammen D. P., Waters R. N., Ballenger J. C., Goodwin F. K., and Bunney W. E. Jr. (1981) Endogenous opioid activity and β-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers. Am. J. Psychiatry 138, 1457-1462.
22. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, London.
23. Risch S. C. (1982) β-Endorphin hypersecretion in depression: possible cholinergic mechanisms. Biol. Psychiatry 17, 1071-1079.
24. Sacerdote P., Brini A., Mantegazza P., and Panerai A. E. (1987) A role for serotonin and beta-endorphin in the analgesia induced by some tricyclic antidepressant drugs. Pharmacol. Biochem. Behav. 26, 153-158.
25. Schreiber S., Backer M. M., Yanai J., and Pick C. G. (1996a) The antinociceptive effect of fluvoxamine. Eur. Neuropsychopharmacol. 6, 281-284.
26. Schreiber S., Backer M. M., Weizman R., and Pick C. G. (1996b) The antinociceptive effects of fluoxetine. Pain Clinic 9, 349-356.
27. Törk I. (1990) Anatomy of the serotonergic system. Ann. NY Acad. Sci. 600, 9-35.
28. Tseng L. F. and Wang Q. (1992) Forebrain sites differentially sensitive to β-endorphin and morphine for analgesia and release of Metenkephalin in the pentobarbital-anesthetized rat. J. Pharmacol. Exp. Ther. 261, 1028-1036.
29. Willner P. (1997) The mesolimbic dopamine system as target for rapid antidepressant action. Int. Clin. Psychopharmacol. 3 (Suppl.), S7-S14.
30. Wise R. A. (1996) Neurobiology of addiction. Curr. Opin. Neurobiol. 6, 243-252.
31. Yadid G., Pacak K., Kopin I. J., and Goldstein D. S. (1994) Endogenous serotonin stimulates striatal dopamine release in conscious rats. J. Pharmacol. Exp. Ther. 270, 1158-1165.
32. Young E. A., Watson S. J., Kotun J., Haskett R. F., Grunhaus L., Murphy-Weinberg V., Vale W., Rivier J., and Akil H. (1990) β-Lipotropin-β-endorphin response to low-dose ovine corticotropin releasing factor in endogenous depression: preliminary studies. Arch. Gen. Psychiatry 47, 449-457.
33. Zakarian S. and Smyth D. G. (1982) Distribution of β-endorphin-related peptide in rat pituitary and brain. Biochem. J. 202, 561-571.
34. Zangen A., Overstreet D. H., and Yadid G. (1997) High serotonin and 5-hydroxyindoleacetic acid levels in limbic brain regions in a rat model of depression: normalization by chronic antidepressant treatment. J. Neurochem. 69, 2477-2483.
35. Zangen A., Hertzberg U., Vogel Z., and Yadid G. (1998) Nociceptive stimulus induces release of endogenous β-endorphin in the rat brain. Neuroscience 85, 659-662.
36. Zangen A., Overstreet D. H., and Yadid G. (1999) Increased catecholamine levels in specific brain regions of a rat model of depression: normalization by chronic antidepressant treatment. Brain Res. 824, 243-250.